Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara

BACKGROUND: The safety and immunogenicity of PfAMA1, adjuvanted with Alhydrogel(®) was assessed in malaria–experienced Malian adults. The malaria vaccine, PfAMA1-FVO [25-545] is a recombinant protein Pichia pastoris-expressed AMA-1 from Plasmodium falciparum FVO clone adsorbed to Alhydrogel(®), the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Malar J
Main Authors: Thera, Mahamadou A., Coulibaly, Drissa, Kone, Abdoulaye K., Guindo, Ando B., Traore, Karim, Sall, Abdourhamane H., Diarra, Issa, Daou, Modibo, Traore, Idrissa M., Tolo, Youssouf, Sissoko, Mady, Niangaly, Amadou, Arama, Charles, Baby, Mounirou, Kouriba, Bourema, Sissoko, Mahamadou S., Sagara, Issaka, Toure, Ousmane B., Dolo, Amagana, Diallo, Dapa A., Remarque, Edmond, Chilengi, Roma, Noor, Ramadhani, Sesay, Sanie, Thomas, Alan, Kocken, Clemens H., Faber, Bart W., Imoukhuede, Egeruan Babatunde, Leroy, Odile, Doumbo, Ogobara K.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006270/
https://ncbi.nlm.nih.gov/pubmed/27577237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-016-1466-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados